PERIPHERAL NERVOUS SYSTEM AGENTS
Clinical trials for PERIPHERAL NERVOUS SYSTEM AGENTS explained in plain language.
Never miss a new study
Get alerted when new PERIPHERAL NERVOUS SYSTEM AGENTS trials appear
Sign up with your email to follow new studies for PERIPHERAL NERVOUS SYSTEM AGENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a ketamine mist lift the fog of severe depression?
Symptom relief Recruiting nowThis study tests whether breathing in a mist of ketamine can quickly reduce symptoms of moderate to severe depression in hospitalized adults. About 40 participants will receive either ketamine or an active placebo (midazolam) to see if the ketamine mist works better. The goal is …
Matched conditions: PERIPHERAL NERVOUS SYSTEM AGENTS
Phase: PHASE3 • Sponsor: Theresa Jacob, PhD, MPH • Aim: Symptom relief
Last updated May 26, 2026 03:57 UTC
-
New injection aims to smooth neck bands in major trial
Symptom relief Recruiting nowThis study tests an injection called NT 201 (a type of botulinum toxin) against a placebo to see if it safely reduces the appearance of moderate to severe neck bands (platysma prominence) in adults. About 300 participants in Europe will receive either the treatment or a placebo, …
Matched conditions: PERIPHERAL NERVOUS SYSTEM AGENTS
Phase: PHASE3 • Sponsor: Merz Aesthetics GmbH • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
NIH launches study to decode depression and suicide risk
Knowledge-focused Recruiting nowThis study follows 500 adults with depression, bipolar disorder, or suicide risk who are already receiving care. Researchers will use interviews, questionnaires, and optional tests like blood draws and brain scans to track how symptoms change over time. The goal is to find better…
Matched conditions: PERIPHERAL NERVOUS SYSTEM AGENTS
Sponsor: National Institute of Mental Health (NIMH) • Aim: Knowledge-focused
Last updated May 26, 2026 03:46 UTC